Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract

AIDS

Volumn 27, Issue 1, 2013, Pages 39-47

  Gianella, Sara ^a   Morris, Sheldon R ^b   Anderson, Christy ^b   Spina, Celsa A ^a,c   Vargas, Milenka V ^a   Young, Jason A ^b   Richman, Douglas D ^a,c   Little, Susan J ^b   Smith, Davey M ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

cytomegalovirus; genital tract; herpes virus; HIV; HIV drug resistance; men who have sex with men; seminal shedding

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; VIRUS RNA;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT INFECTION; MALE HOMOSEXUAL; MIXED INFECTION; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEMEN ANALYSIS; VIRUS MUTATION; VIRUS REPLICATION; VIRUS SHEDDING;

ADULT; CALIFORNIA; CD4 LYMPHOCYTE COUNT; COINFECTION; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; GENITALIA, MALE; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MUTATION; RETROSPECTIVE STUDIES; RNA, VIRAL; SEMEN; VIRUS SHEDDING;

EID: 84871622399     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283573305     Document Type: Article

References (48)

1. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921.
2. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153. (Pubitemid 32378686)
3. Butler DM, Smith DM, Cachay ER, Hightower GK, Nugent CT, Richman DD, et al. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS 2008; 22:1667-1671.
4. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011; 3:77ra29.
5. Pinto-Neto LF, Vieira NF, Soprani M, Cunha CB, Dietze R, Ribeiro-Rodrigues R. Lack of correlation between seminal and plasma HIV-1 viral loads is associated with CD4 T cell depletion in therapy-naive HIV-1R patients. Mem Inst Oswaldo Cruz 2002; 97:563-567. (Pubitemid 135746804)
6. Speck CE, Coombs RW, Koutsky LA, Zeh J, Ross SO, Hooton TM, et al. Risk factors for HIV-1 shedding in semen. Am J Epidemiol 1999; 150:622-631. (Pubitemid 29426907)
7. Kalichman SC, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008; 35:55-60. (Pubitemid 351619353)
8. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2:33-42. (Pubitemid 39490046)
9. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-1873. (Pubitemid 27270120)
10. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008; 35:946-959.
11. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28:579-597. (Pubitemid 32937567)
12. Gianella S, Strain MC, Rought SE, Vargas M, Little SJ, Richman DD, et al. Associations between the virologic and immunologic dynamics in blood and in the male genital tract. J Virol 2012; 86:1307-1315.
13. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007; 196:1500-1508. (Pubitemid 351411987)
14. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and metaanalysis of longitudinal studies. AIDS 2006; 20:73-83. (Pubitemid 41818117)
15. Sheth PM, Danesh A, Sheung A, Rebbapragada A, Shahabi K, Kovacs C, et al. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J Infect Dis 2006; 193:45-48. (Pubitemid 43032497)
16. Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, et al. Semen of HIV-1-infected individuals: local shedding of herpes viruses and reprogrammed cytokine network. J Infect Dis 2012; 205:97-105.
17. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186:1718-1725. (Pubitemid 35463503)
18. Mbopi-Keou FX, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Matta M, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090-1096.
19. Baeten JM, McClelland RS, Corey L, Overbaugh J, Lavreys L, Richardson BA, et al. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial. J Infect Dis 2004; 189:1466-1471. (Pubitemid 38543596)
20. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
21. Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, et al. Semen of HIV-1-infected individuals: local shedding of herpes viruses and reprogrammed cytokine network. J Infect Dis 2012; 205:97-105.
22. Lisco A, Vanpouille C, Margolis L. War and peace between microbes: HIV-1 interactions with coinfecting viruses. Cell Host Microbe 2009; 6:403-408.
23. Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, et al. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients. J Clin Virol 2012; 53:195-200.
24. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, et al. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol 2008; 82:5510-5518. (Pubitemid 351705258)
25. Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman DD, Little SJ. The prostate as a reservoir for HIV-1. AIDS 2004; 18:1600.
26. Butler DM, Delport W, Kosakovsky Pond SL, Lakdawala MK, Cheng PM, Little SJ, et al. The origins of sexually transmitted HIV among men who have sex with men. Sci Transl Med 2010; 2:18re11.
27. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-1879. (Pubitemid 37070272)
28. Kosakovsky Pond SL, Posada D, Stawiski E, Chappey C, Poon AF, Hughes G, et al. An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol 2009; 5:e1000581.
29. Shafer RW, Stevenson D, Chan B. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 1999; 27:348-352. (Pubitemid 29209482)
30. Althaus CF, Gianella S, Rieder P, von Wyl V, Kouyos RD, Niederost B, et al. Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance. J Virol Methods 2010; 165:151-160; (Authors contributed equally to the manuscript. ).
31. Yen-Lieberman B, Brambilla D, Jackson B, Bremer J, Coombs R, Cronin M, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol 1996; 34:2695-2701. (Pubitemid 26346488)
32. Barbour JD, Wrin T, Grant RM, Martin JN, Segal MR, Petropoulos CJ, et al. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults. J Virol 2002; 76:11104-11112. (Pubitemid 35176226)
33. Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, et al. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 2001; 344:472-480. (Pubitemid 32164898)
34. WHO. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people, (2011). http://whqlibdoc. who. int/publications/2011/9789241501750-eng. pdf [Accessed January 2012].
35. Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, et al. Valganciclovir reduces T cell activation in HIVinfected individuals with incomplete CD4R T cell recovery on antiretroviral therapy. J Infect Dis 2011; 203:1474-1483.
36. Aumakhan B, Gange SJ, Beyrer C, Gaydos CA, Minkoff H, Merenstein DJ, et al. Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study. Int J STD AIDS 2011; 22:273-277.
37. Sheth PM, Yi TJ, Kovacs C, Kemal KS, Jones RB, Osborne B, et al. Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy. Mucosal Immunol 2012; 5:248-257.
38. Reischig T, Prucha M, Sedlackova L, Lysak D, Jindra P, Bouda M, et al. Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients. Antivir Ther 2011; 16:1227-1235.
39. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, et al. Risk factors for human herpes virus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007; 196:199-207. (Pubitemid 47047458)
40. O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, et al. Evidence for concurrent epidemics of human herpes virus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999; 180:1010-1017. (Pubitemid 30070181)
41. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, et al. Risk factors for Kaposi's-sarcoma-associated herpes virus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77:543-548. (Pubitemid 28340901)
42. Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, et al. Valganciclovir for suppression of human herpes virus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 2008; 198:23-30. (Pubitemid 351920285)
43. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, et al. Mucosal shedding of human herpes virus 8 in men. N Engl J Med 2000; 343:1369-1377.
44. Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, Hawes SE, et al. HIV infection and human herpes virus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr 2004; 35:233-238. (Pubitemid 38280648)
45. Casper C, Krantz E, Selke S, Kuntz SR, Wang J, Huang ML, et al. Frequent and asymptomatic oropharyngeal shedding of human herpes virus 8 among immunocompetent men. J Infect Dis 2007; 195:30-36. (Pubitemid 44958224)
46. Shebl FM, Dollard SC, Pfeiffer RM, Biryahwaho B, Amin MM, Munuo SS, et al. Human herpes virus 8 seropositivity among sexually active adults in Uganda. PLoS One 2011; 6:e21286.
47. Ogoina D, Onyemelukwe G, Musa BO, Babadoko A. Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection. Afr Health Sci 2011; 11:158-162.
48. Zhang T, He N, Ding Y, Crabtree K, Minhas V, Wood C. Prevalence of human herpes virus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China. Clin Microbiol Infect 2011; 17:395-401.